This intratumoral infiltration with CD4+ and CD8+ T cells was also seen in preclinical glioblastoma (GL26 glioma-bearing C57BL/6 mice) after immunomodulatory treatment [55]. This evidence concerns the gene CD8A and central nervous system cancer.